Literature DB >> 30095401

Feasibility of structured light plethysmography for the evaluation of lung function in preschool children with asthma.

Michele Ghezzi, Laura Tenero, Michele Piazza, Marco Zaffanello, Giulia Paiola, Giorgio L Piacentini.   

Abstract

BACKGROUND: Structured light plethysmography (SLP) is a new noninvasive technology to capture the movement of the thoracic and abdominal wall, and to assess some parameters indicative for lung function.
OBJECTIVE: The purpose of the study was to evaluate the feasibility of SLP in children with asthma.
METHODS: A total of 52 patients were enrolled: 25 with asthma exacerbation (group 1), 13 with well-controlled asthma (group 2), and 14 healthy controls (group 3). Every patient underwent SLP evaluation and a lung function test.
RESULTS: SLP evaluations showed that the ratio of inspiratory flow at 50% of tidal volume (Vt) to expiratory flow at 50% of Vt, in which Vt is taken to be the exhaled chest wall movement, and flow is taken to be the time derivative of the chest wall movement (IE50) value increased in group 1 compared with groups 2 and 3, with statistical significance (p = 0.018); the data were consistent with the spirometry parameter. A correlation between the IE50 and forced expiratory volume in the first second of expiration was highlighted (r = -0.35, p = 0.019).
CONCLUSION: SLP assessed airway obstruction, and its use in clinical practice could be applied in preschool children in future studies.

Entities:  

Mesh:

Year:  2018        PMID: 30095401     DOI: 10.2500/aap.2018.39.4143

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  2 in total

1.  Usefulness of sRtot and Rint in bronchodilator testing in the diagnosis of asthma in children.

Authors:  Monika Bobrowska-Korzeniowska; Agnieszka Brzozowska; Joanna Jerzyńska; Włodzimierz Stelmach; Iwona Stelmach
Journal:  Postepy Dermatol Alergol       Date:  2020-11-07       Impact factor: 1.837

2.  Children are not small adults.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2018-07-01       Impact factor: 2.873

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.